Ryan & Maniskas, LLP Announces Investigation of Caraco Pharmaceutical Laboratories, Ltd.
06 Dicembre 2010 - 10:20PM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/cpd) is
investigating potential claims against the board of directors of
Caraco Pharmaceutical Laboratories, Ltd. ("Caraco" or the
"Company") (AMEX: CPD) concerning the Company’s receipt of a
proposal from Sun Pharmaceutical Industries Ltd. (“Sun”) and Sun
Pharma Global, Inc. (“Sun Global”) to acquire the remainder of the
Company Sun and Sun Global do not already own in a transaction
valued at approximately $188 million.
Our investigation concerns whether Caraco’s Board undertook a
fair process to obtain fair consideration for all shareholders of
Caraco; in particular, whether the Company's Board breached their
fiduciary duties to Caraco shareholders by failing to adequately
shop the Company. For more information regarding our investigation,
please contact Ryan & Maniskas, LLP (Richard A. Maniskas,
Esquire) toll-free at (877) 316-3218 or by email at
rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/cpd.
Under the terms of the proposed transaction, Caraco shareholders
are to receive $4.75 in cash for each share they own, which
represents a 5% premium over the closing price of Caraco common
stock on December 2, 2010. Sun and Sun Global already own
approximately 75.8% of the Company’s outstanding shares.
If you own shares of Caraco and would like to learn more about
these claims or if you wish to discuss these matters and have any
questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/cpd. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide.
Grafico Azioni Caraco (AMEX:CPD)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Caraco (AMEX:CPD)
Storico
Da Feb 2024 a Feb 2025
Notizie in Tempo Reale relative a Caraco Pharmaceutical Laboratories, Ltd. Common Stock (Borsa Americana (AMEX)): 0 articoli recenti
Più Ryan & Maniskas, LLP Articoli Notizie